BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Saxatilin Suppresses Tumor-induced Angiogenesis by Regulating VEGF Expression in NCI-H460 Human Lung Cancer Cells

  • Jang, Yoon-Jung (Department of Biochemistry, College of Science, Yonsei University) ;
  • Kim, Dong-Seok (Department of Biochemistry, College of Science, Yonsei University) ;
  • Jeon, Ok-Hee (Department of Biochemistry, College of Science, Yonsei University) ;
  • Kim, Doo-Sik (Department of Biochemistry, College of Science, Yonsei University)
  • Published : 2007.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Tumor growth and metastasis are dependent on angiogenesis, and endothelial cell invasion and migration are apparent means of regulating tumor progression. We report here that saxatilin, a snake venom-derived disintegrin, suppresses the angiogenesis-inducing properties of NCI-H460 human lung cancer cells. Culture supernatants of NCI-H460 cells are able to induce human umbilical vascular endothelial cell (HUVEC) invasion and tube formation. However, treatment of the cancer cells with saxatilin resulted in reduced angiogenic activity of the culture supernatant. This suppressed angiogenic property was found to be associated with the level of vascular endothelial growth factor (VEGF) in the culture supernatant. Further experimental evidence indicated that saxatilin inhibits VEGF production in NCI-H460 cells by affecting hypoxia induced factor-1$\alpha$ (HIF-1$\alpha$) expression via the Akt pathway.

Keywords

References

  1. Berger A. P., Kofler K., Bektic J., Rogatsch H., Steiner H., Bartsch G. and Klocker, H. (2003) Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia. Prostate 57, 57-65. https://doi.org/10.1002/pros.10279
  2. Breier G. and Risau W. (1996) The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol. 6, 454-456. https://doi.org/10.1016/0962-8924(96)84935-X
  3. Brooks P. C., Clark R. and Cheresh D. A. (1994) Requirement of vascular integrin $\alpha$$\nu$$\beta$3 for angiogenesis. Science 264, 569-571. https://doi.org/10.1126/science.7512751
  4. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau,, E. J., Senger, D. R. and Dvorak, H. F. (1993) expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 53, 4727-4735.
  5. Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., and Dvorak, H. F. (1997) Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. EXS 79, 233-269.
  6. Chang, H., Shyu, K., Lee, C., Tsai, S., Wang, B., Lee, Y. and Lin, S. (2003) GL331 inhibits HIF-1$\alpha$ expression in a lung cancer model. Biochem. Biophys. Res. Commun. 302, 95-100 https://doi.org/10.1016/S0006-291X(03)00111-6
  7. Chung C. H., Wu W. B. and Huang T. F. (2004) Aggretin, a snake venom-derived endothelial integrin alpha 2 beta 1 agonist, induces angiogenesis via expression of vascular endothelial growth factor. Blood 103, 2105-2113. https://doi.org/10.1182/blood-2003-07-2483
  8. Ferrara, N. and Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25. https://doi.org/10.1210/er.18.1.4
  9. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31. https://doi.org/10.1038/nm0195-27
  10. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1. Mol. Cell. Biol. 16, 4604-4613. https://doi.org/10.1128/MCB.16.9.4604
  11. Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M. and Reme, C. E. (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8, 718-724. https://doi.org/10.1038/nm723
  12. Gleadle J. M. and Ratcliffe P. J. (1997) Induction of hypoxiainducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood 89, 503-509.
  13. Hong, S. Y., Koh, Y. S., Chung, K. H. and Kim, D. S. (2002a) Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration. Thromb. Res. 105, 79-86. https://doi.org/10.1016/S0049-3848(01)00416-9
  14. Hong, S. Y., Sohn, Y. D., Chung, K. H. and Kim, D. S. (2002b) Structural and functional significance of disulfide bonds in saxatilin, a 7.7 kDa disintegrin. Biochem. Biophys. Res. Commun. 293, 530-536. https://doi.org/10.1016/S0006-291X(02)00258-9
  15. Jaffe, E. A., Nachman, R. L., Becker, C. G. and Minick, C. R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756. https://doi.org/10.1172/JCI107470
  16. Joseph, I. B., Selson, J. B., Denmeade, S. R. and Isaacs, J. T. (1997) Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin. Cancer Res. 3, 2507-2511
  17. Jubb, A. M., Pham, T. Q., Hanby, A. M., Frantz, G. D., Peale, F. V., Wu, T. D., Koeppen, H. W. and Hillan, K. J. (2004) Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumors. J. Clin. Pathol. 57, 504-512. https://doi.org/10.1136/jcp.2003.012963
  18. Kang, H. Y., Shim, D., Kang, S. S., Chang, S. I. and Kim, H. Y. (2006) Protein kinase B inhibits endostatin-induced apoptosis in HUVECs. J. Biochem. Mol. Biol. 39, 97-104. https://doi.org/10.5483/BMBRep.2006.39.1.097
  19. Kang, I. C., Chung, K. H., Lee, S. J., Yun, Y. D., Moon, H. M. and Kim, D. S. (1998) Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon Hays Brevicaudus) venom. Thromb. Res. 91, 65-73. https://doi.org/10.1016/S0049-3848(98)00053-X
  20. Kang, I. C., Lee, Y. D. and Kim, D. S. (1999) A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res. 59, 3754-3760.
  21. Kang, I. C., Kim, D. S., Jang, Y. and Chung, K. H. (2000) Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis. Biochem. Biophys. Res. Commun. 275, 169-173. https://doi.org/10.1006/bbrc.2000.3130
  22. Kubota, Y., Kleinman, H. K., Martin G. R. and Lawley T. J. (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107, 1589-1598. https://doi.org/10.1083/jcb.107.4.1589
  23. Ohta, Y., Endo, Y., Tanaka, M., Shimizu, J., Oda, M., Hayashi, Y., Watanabe, Y. and Sasaki, T. (1996) Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res. 2, 1411-1416.
  24. Petruzelli, G. J., Snyderman, C. H., Johnson, J. T. and Myers, E. N. (1993) Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embryo chorioallantoic membrane model. Ann. Otol. Rhinol. Laryngol. 102, 212-221.
  25. Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671-674. https://doi.org/10.1038/386671a0
  26. Shi, Y. H., Wang, Y. X., Bingle, L., Gong, L. H., Heng, W. J., Li, Y. and Fang, W. G. (2005) In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J Pathol. 205, 530-536. https://doi.org/10.1002/path.1734
  27. Shibuya, M. (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem. Mol. Biol. 39, 469-478. https://doi.org/10.5483/BMBRep.2006.39.5.469
  28. Shima, D. T., Kuroki M., Deutsch U., Ng Y. S., Adamis A. P., and D'Amore P. A. (1996) The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271, 3877-3883. https://doi.org/10.1074/jbc.271.7.3877
  29. Stromblad, S. and Cheresh, D. A. (1996) Integrins, angiogenesis and vascular cell survival. Chem. Biol. 3, 881-885. https://doi.org/10.1016/S1074-5521(96)90176-3
  30. Tan, C., Cruet-Hennequart, S., Troussard, A., Fazli, L., Costello, P., Sutton, K., Wheeler, J., Gleave M., Sanghera J. and Dedhar S. (2004) Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer Cell 5, 79-90. https://doi.org/10.1016/S1535-6108(03)00281-2
  31. Ueda, S., Basaki, Y., Yoshie, M., Ogawa, K., Sakisaka, S., Kuwano, M. and Ono, M. (2006) PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib. Cancer Res. 66, 5346-5353. https://doi.org/10.1158/0008-5472.CAN-05-3684
  32. Yeh, C. H., Peng, H. C. and Huang, T. F. (1998) Accutin, a New Disintegrin, Inhibits Angiogenesis In Vitro and In Vivo by Acting as Integrin $\alpha$Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis$\beta$3 Antagonist and Inducing Apoptosis Blood 92, 3268-3276.
  33. Wu, C. and Dedhar, S. (2001) Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J. Cell Biol. 155, 501-505. https://doi.org/10.1083/jcb.200110066
  34. Zhong, H., Mabjeesh, N., Willard, M. and Simons, J. (2002) Nuclear expression of hypoxia-inducible factor 1alpha protein is heterogeneous in human malignant cells under normoxic conditions. Cancer Lett. 181, 233-238. https://doi.org/10.1016/S0304-3835(02)00053-8

Cited by

  1. Snake Venom Disintegrins and Cell Migration vol.2, pp.11, 2010, https://doi.org/10.3390/toxins2112606
  2. cDNA cloning of a snake venom metalloproteinase from the eastern diamondback rattlesnake (Crotalus adamanteus), and the expression of its disintegrin domain with anti-platelet effects vol.64, 2013, https://doi.org/10.1016/j.toxicon.2012.12.025
  3. H460 non-small cell lung cancer stem-like holoclones yield tumors with increased vascularity vol.346, pp.1, 2014, https://doi.org/10.1016/j.canlet.2013.12.012
  4. Development of novel inhibitors targeting HIF-1α towards anticancer drug discovery vol.20, pp.22, 2010, https://doi.org/10.1016/j.bmcl.2010.09.083
  5. AA092, an annonaceous acetogenin mimetic, attenuates angiogenesis in a mouse model of inflammation-induced corneal neovascularization vol.28, pp.2, 2015, https://doi.org/10.1016/j.intimp.2015.08.009
  6. DisBa-01 inhibits angiogenesis, inflammation and fibrogenesis of sponge-induced-fibrovascular tissue in mice vol.92, 2014, https://doi.org/10.1016/j.toxicon.2014.10.007
  7. Inhibition of leukemic U937 cell growth by induction of apoptosis, cell cycle arrest and suppression of VEGF, MMP-2 and MMP-9 activities by cytotoxin protein NN-32 purified from Indian spectacled cobra (Naja naja) venom vol.65, 2013, https://doi.org/10.1016/j.toxicon.2013.01.004
  8. Nanomaterials for Theranostics: Recent Advances and Future Challenges vol.115, pp.1, 2015, https://doi.org/10.1021/cr300213b
  9. Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling vol.98, pp.8, 2008, https://doi.org/10.1038/sj.bjc.6604319
  10. Inhibition effects of gold nanoparticles on proliferation and migration in hepatic carcinoma-conditioned HUVECs vol.24, pp.2, 2014, https://doi.org/10.1016/j.bmcl.2013.11.045
  11. VEGF and angiogenesis in acute and chronic MOG(35–55) peptide induced EAE vol.209, pp.1-2, 2009, https://doi.org/10.1016/j.jneuroim.2009.01.009
  12. Anti-angiogenic potential of an ethanol extract of Annona atemoya seeds in vitro and in vivo vol.14, pp.1, 2014, https://doi.org/10.1186/1472-6882-14-353
  13. The predictive value of vascular endothelial growth factor and Ki-67 expression on neoadjuvant therapy in rectal cancer vol.8, pp.1, 2009, https://doi.org/10.1007/s10330-008-0149-1